Yes, it's still early - but research results like this make me do a happy dance!!! _________ Impactiviti is the Pharmaceutical Connection Agency. As the eHarmony of sales/training/marketing, we …
Impactiviti Daily 021910
TODAY’S NEWS Big news on the leukemia front: Novartis' Tasigna gets priority FDA review for newly-diagnosed patients; and Roche/Genentech's Rituxan approved for CLL. A quarter of new prescriptions …
August ’08 Pharma News
The Xa factor: not looking so promising for Pfizer and Bristol - Bristol-Myers Squibb and Pfizer's apixaban blood clot preventer raised rates of bleeding in a 6-month study but showed some encouraging …